Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset.
Ontology highlight
ABSTRACT: Rift Valley fever virus (RVFV) is an emerging mosquito-borne bunyavirus that is highly pathogenic to wild and domesticated ruminants, camelids, and humans. While animals are exclusively infected via mosquito bites, humans can also be infected via contact with contaminated tissues or blood. No human vaccine is available and commercialized veterinary vaccines do not optimally combine efficacy with safety. We previously reported the development of two novel live-attenuated RVF vaccines, created by splitting the M genome segment and deleting the major virulence determinant NSs. The vaccine candidates, referred to as the veterinary vaccine vRVFV-4s and the human vaccine hRVFV-4s, were shown to induce protective immunity in multiple species after a single vaccination. Anticipating accidental exp
SUBMITTER: Wichgers Schreur PJ
PROVIDER: S-EPMC9117246 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature
ACCESS DATA